Last $0.54 USD
Change Today 0.00 / 0.00%
Volume 2.0K
CYIG On Other Exchanges
Symbol
Exchange
OTC US
Stuttgart
As of 8:10 PM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

china yct international (CYIG) Snapshot

Open
$0.54
Previous Close
$0.54
Day High
$0.54
Day Low
$0.54
52 Week High
06/2/14 - $1.24
52 Week Low
09/30/13 - $0.15
Market Cap
16.0M
Average Volume 10 Days
2.5K
EPS TTM
$0.26
Shares Outstanding
29.7M
EX-Date
--
P/E TM
2.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA YCT INTERNATIONAL (CYIG)

Related News

No related news articles were found.

china yct international (CYIG) Related Businessweek News

No Related Businessweek News Found

china yct international (CYIG) Details

China YCT International Group, Inc., through its subsidiaries, is engaged in developing, manufacturing, and marketing gingko; and distributing other dietary supplement products in the People’s Republic of China. It provides Huoliyuan capsule for the treatment of chronic hepatitis, diabetes, insomnia, memory loss, menopause syndrome, and other maladies. The company also offers 10 health care supplement products. China YCT International Group, Inc. sells its products to individual retail customers. The company is based in Sishui County, the People’s Republic of China.

china yct international (CYIG) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $49.7K
Chief Financial Officer
Total Annual Compensation: $33.5K
Compensation as of Fiscal Year 2014.

china yct international (CYIG) Key Developments

CYIG Signs Strategic Cooperation Agreement with Xi'an Putian Pharmacy

China YCT International Group Inc. (CYIG) signed a strategic cooperation agreement with Xi'an Putian Pharmacy LLP on August 8, 2014. Therefore, Putian Pharmacy, as the sales agency, will be allowed to sell Huoliyuan capsules in 15 Chinese provinces, which indicates that the sales network of Huoliyuan capsules has captured all provincial markets in China by expanding market share as well as increasing unit sales. CYIG mainly focused on producing medicines and selling organic healthcare products. It is also dedicated to laying a solid foundation for building a nationwide sales and marketing network. Additionally, CYIG will be offering more incentives to strategic partners to encourage them to create more value for CYIG.

China YCT International Group, Inc Reports Earnings Results for the Year Ended March 31, 2014

China YCT International Group Inc. reported earnings results for the year ended March 31, 2014. For the year, net income was $8.12 million, or $0.27 per share, compared to $15.26 million, or $0.28 per share for the year ended March 31, 2013. Sales revenue for the year ended March 31, 2014 was $34.06 million, compared to $33.1 million for the year ended March 31, 2013. Income from operation for the year ended March 31, 2014 was $10.72 million, compared to $9.18 million for the year ended March 31, 2013.

China YCT International Group, Inc announced delayed 10-Q filing

On 02/14/2014, China YCT International Group, Inc announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYIG:US $0.54 USD 0.00

CYIG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CYIG.
View Industry Companies
 

Industry Analysis

CYIG

Industry Average

Valuation CYIG Industry Range
Price/Earnings 2.0x
Price/Sales 0.5x
Price/Book 0.2x
Price/Cash Flow 2.0x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA YCT INTERNATIONAL, please visit www.yctgroup.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.